Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chirikov

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Transarterial chemoembolization treatment: association between multiple treatments, cumulative expenditures, and survivalIan M Breunig, Fadia T Shaya, Nader Hanna, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|July 19, 2021
Nonlinear theory of macroscopic flow induced in a drop of ferrofluidAndrey Yu Zubarev, Dmitry Chirikov, Anton Musikhin, et al.
American Journal of Clinical Oncology|September 26, 2013
Multispecialist Care and Mortality in Hepatocellular CarcinomaViktor V Chirikov, C Daniel Mullins, Nader Hanna, et al.
Clinical and Translational Gastroenterology|August 25, 2023
Terlipressin vs Midodrine Plus Octreotide for Hepatorenal Syndrome-Acute Kidney Injury: A Propensity Score-Matched ComparisonStevan A Gonzalez, Viktor V Chirikov, Wei-Jhih Wang, et al.
Expert Review of Gastroenterology & Hepatology|November 3, 2015
Determinants of quality of care and treatment initiation in Medicare disabled patients with chronic hepatitis CViktor V Chirikov, Fadia T Shaya, C Daniel Mullins, et al.
Journal of the American Pharmacists Association : Japha|October 23, 2016
Clinical effectiveness and cost savings in diabetes care, supported by pharmacist counsellingMagaly Rodriguez de Bittner, Viktor V Chirikov, Ian M Breunig, et al.
Pharmacoeconomics|December 3, 2013
Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-MedicareFadia T Shaya, Ian M Breunig, Brian Seal, et al.
Ethnicity & Disease|May 9, 2014
Diabetes control through an educational interventionWallace Johnson, Fadia T Shaya, Reed Winston, et al.
Dermatology and Therapy|July 31, 2023
Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque PsoriasisApril W Armstrong, Sang Hee Park, Vardhaman Patel, et al.
Clinical Therapeutics|September 9, 2023
Association Between Intermediate End Points, Progression-free Survival, and Overall Survival in First-line Advanced or Recurrent Endometrial CancerJamie Garside, Qin Shen, Bernd Westermayer, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Transarterial chemoembolization treatment: association between multiple treatments, cumulative expenditures, and survivalIan M Breunig, Fadia T Shaya, Nader Hanna, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|July 19, 2021
Nonlinear theory of macroscopic flow induced in a drop of ferrofluidAndrey Yu Zubarev, Dmitry Chirikov, Anton Musikhin, et al.
American Journal of Clinical Oncology|September 26, 2013
Multispecialist Care and Mortality in Hepatocellular CarcinomaViktor V Chirikov, C Daniel Mullins, Nader Hanna, et al.
Clinical and Translational Gastroenterology|August 25, 2023
Terlipressin vs Midodrine Plus Octreotide for Hepatorenal Syndrome-Acute Kidney Injury: A Propensity Score-Matched ComparisonStevan A Gonzalez, Viktor V Chirikov, Wei-Jhih Wang, et al.
Expert Review of Gastroenterology & Hepatology|November 3, 2015
Determinants of quality of care and treatment initiation in Medicare disabled patients with chronic hepatitis CViktor V Chirikov, Fadia T Shaya, C Daniel Mullins, et al.
Journal of the American Pharmacists Association : Japha|October 23, 2016
Clinical effectiveness and cost savings in diabetes care, supported by pharmacist counsellingMagaly Rodriguez de Bittner, Viktor V Chirikov, Ian M Breunig, et al.
Pharmacoeconomics|December 3, 2013
Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-MedicareFadia T Shaya, Ian M Breunig, Brian Seal, et al.
Ethnicity & Disease|May 9, 2014
Diabetes control through an educational interventionWallace Johnson, Fadia T Shaya, Reed Winston, et al.
Dermatology and Therapy|July 31, 2023
Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque PsoriasisApril W Armstrong, Sang Hee Park, Vardhaman Patel, et al.
Clinical Therapeutics|September 9, 2023
Association Between Intermediate End Points, Progression-free Survival, and Overall Survival in First-line Advanced or Recurrent Endometrial CancerJamie Garside, Qin Shen, Bernd Westermayer, et al.
Pageof 11